Datalyze Corp (TSE:NDAT) has released an update. nDatalyze Corp. has announced a non-binding Letter of Intent to engage in a reverse takeover ...

“This reverse merger represents a US$452 million transaction at a deemed price of US$3.20 per share —a significant milestone that we believe will enhance market visibility while supporting our ...

NewGenIvf Group (NIVF) announced that both parties involved in the previously announced reverse merger with European Wellness Investment ...

A pharmaceutical company founded by Houston medical leaders is set to go public via a merger, and it’s staying in town.